RemedyRePack Clindamycin HCl Capsule Recall: FDA Class II

Why it was recalled

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Product description

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Lot numbers, UPCs & expiration codes

Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.

Where it was sold

Within U.S - PA, VA, FL.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0411-2025
Classification: Class II
Status: Ongoing
Recall initiated: Apr 22, 2025
FDA report date: May 14, 2025
Quantity: 23 bottles/30 count- 690 capsules
Recall type: Voluntary: Firm initiated
Recalling firm: RemedyRePack Inc.

Original FDA data

Every field from FDA enforcement report D-0411-2025, exactly as published.

Show all FDA fields

City: Indiana
State: PA
Status: Ongoing
Country: United States
Event ID: 96764
Address: 625 Kolter Dr Ste 4
Code information: Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
Postal code: 15701-3571
Report date: May 14, 2025
Product type: Drugs
Recall number: D-0411-2025
Classification: Class II
Recalling firm: RemedyRePack Inc.
Product quantity: 23 bottles/30 count- 690 capsules
Reason for recall: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Distribution pattern: Within U.S - PA, VA, FL.
Recall initiation date: Apr 22, 2025
Initial firm notification: E-Mail
Center classification date: May 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0411-2025, published May 14, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

RemedyRePack Clindamycin HCl Capsule Recall

Summary